SonoSite revenues drop in 3Q
Revenues dropped 13% to $53.6 million for SonoSite in the third quarter compared with the year earlier period.
SonoSite revenues drop in 3Q
Revenues dropped 13% to $53.6 million for SonoSite in the third quarter compared with the year earlier period. The most recent quarter showed a deteriorating marketplace for the pioneer of hand-carried ultrasound as nine month revenues were down 9% compared with the first nine months of 2008. Foreign exchange had zero effect on third quarter revenue, according to the company, but a negative impact of $6.7 million or 4% for the nine months just ended. For the third quarter of 2009, the company recorded a net loss of $0.2 million compared with a net income of $3.7 million in 2008. For the nine months of 2009, net income was $1.0 million compared with $5.3 million. Kevin M. Goodwin, SonoSite president and CEO, said U.S. revenue levels continued to stabilize and the company ran into “a few” order delays in its international business. Importantly, he said, pricing and expense management have improved, resulting in steadily increasing operating margin performance.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
